Malin Corporation | MLC - Current Liabilities


Malin Corporation reported EUR1000K in Current Liabilities for its fiscal semester ending in December of 2024.





Current Liabilities Change Date
Akebia Therapeutics USD 173.88M 10.95M Mar/2026
Alaunos Therapeutics USD 595K 218K Mar/2026
ALKERMES USD 599.5M 56.06M Mar/2026
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 38.28M 7.55M Mar/2026
Eurofins Scientific SE EUR 2.43B 344.6M Dec/2025
Ionis Pharmaceuticals USD 717M 66M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
Lonza CHF 3.57B 421M Dec/2025
Malin Corporation EUR 1000K 500K Dec/2024
Moderna USD 2.4B 408M Mar/2026
Organon & Co USD 2.5B 110M Mar/2026
Ovoca Bio EUR 186K 2.26M Jun/2025
Revvity USD 1.24B 92.6M Mar/2026
Tectonic Therapeutic USD 12.96M 3.29M Mar/2026
Viatris USD 6.81B 284M Mar/2026
Xeris Pharmaceuticals USD 118.59M 9.02M Mar/2026